SPI1 suppresses YAP phosphorylation in vascular endothelial cells to prevent intracranial aneurysm progression

Yikui Liu1, Danyi Zheng2, Lanlan Zhao3

  • 1Department of Neurosurgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

PubMed

Insights

Turbulent flow in intracranial aneurysms (IAs) reduces YAP expression, promoting endothelial cell senescence. SPI1 overexpression counteracts this, offering a potential therapeutic target for IA treatment.

Area of Science:

  • Vascular Biology
  • Cellular Mechanisms
  • Aneurysm Pathogenesis

Background:

  • Intracranial aneurysms (IAs) involve complex endothelial cell (EC) dysfunction.
  • The role of YAP in ECs within the context of IA development is not fully understood.

Purpose of the Study:

  • To investigate the mechanism of YAP in mediating EC activity during IA formation.
  • To identify novel therapeutic targets for noninvasive IA treatment.

Main Methods:

  • Single-nuclei RNA sequencing of aneurysmal cells.
  • Immunostaining of human IA tissues and temporal artery walls.
  • YAP knockdown in human brain microvascular endothelial cells (HBMECs).
  • SPI1 (PU.1) overexpression studies.

Main Results:

  • ECs in IAs display an intermediate arterial/venous/capillary identity.
  • Turbulent flow downregulates YAP and increases phosphorylated YAP (p-YAP) in ECs.
  • YAP knockdown in HBMECs increases senescence markers (p21, p16) and reduces proliferation/migration.
  • SPI1 overexpression mitigates EC degeneration induced by turbulent flow via YAP phosphorylation suppression.

Conclusions:

  • Turbulent flow accelerates endothelial senescence by reducing YAP expression and increasing its phosphorylation.
  • SPI1 overexpression is a potential therapeutic strategy to prevent IA progression by mitigating EC senescence.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K